fencarbamide: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 6008 |
| CHEMBL ID | 2107472 |
| SCHEMBL ID | 249495 |
| MeSH ID | M0053020 |
| Synonym |
|---|
| bay 1355 |
| escorpal |
| s-(2-(diethylamino)ethyl) diphenylthiocarbamate |
| fencarbamide |
| diphenylthiocarbamic acid s-(2-(diethylamino)ethyl) ester |
| carbamic acid, diphenylthio-, s-(2-(diethylamino)ethyl) ester |
| rispasulf |
| fencarbamida [inn-spanish] |
| phencarbamide [usan] |
| brn 2753271 |
| bayer 1355 |
| carbamothioic acid, diphenyl-, s-(2-(diethylamino)ethyl) ester |
| phencarbamid |
| fencarbamidum [inn-latin] |
| einecs 223-103-4 |
| phencarbamide |
| D05452 |
| escorpal (tn) |
| fencarbamide (inn) |
| 3735-90-8 |
| phencarbamide (usan) |
| CHEMBL2107472 |
| fencarbamidum |
| fencarbamida |
| 59h17j9f1b , |
| unii-59h17j9f1b |
| fencarbamide [inn] |
| phencarbamide [mi] |
| fencarbamide [mart.] |
| fencarbamide [who-dd] |
| s-[2-(diethylamino)ethyl] diphenylthiocarbamate |
| SCHEMBL249495 |
| DTXSID80190796 |
| s-[2-(diethylamino)ethyl] n,n-diphenylcarbamothioate |
| escorpal; fencarbamide; phencarbamid; rispasulf |
| Q27261706 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||